Scientists at the University of California Davis’ Institute for Regenerative Cures are utilizing mesenchymal stem cells [the same type of stem cells found in teeth] to develop a new therapy that targets the genetic abnormality in Huntington’s disease. The principal investigator of the study, and the director of UC Davis stem cell program and the UC Davis Institute for Regenerative Cures, Jan Nolta said, “Our team has made a breakthrough that gives families affected by this disease hope that genetic therapy may one day become a reality.” The treatment seeks to address the root cause of the disease as opposed to merely mitigating the symptoms of the disease.
As gene therapies, such as this one [and other stem cell treatments for disease, trauma and injury] are developed, the promise of translational genomics opens innovative possibilities for medical treatments for those suffering from genetic disorders. Autologous stem cells are an invaluable resource for the successful application of these emerging treatments.
For individuals, or families with a history of genetic disorders, the wisdom of banking your own valuable stem cells when they are young, vital and plentiful therefore becomes apparent. A convenient and affordable method of securing your stem cells is through the dental pulp in teeth, which are readily extracted or are naturally shed during childhood and young adult years. To learn more about stem cells, and how families can now easily preserve their own stem cells for potential use in future therapies, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™